Exchange: NASDAQ·Updated 07:30 PM EST

IAM Iambic Therapeutics Inc.

$13.32
$0.09
(0.67%)
Today
Closed $13.40
$0.08
(0.60%)
After Hours
Mkt Cap$639.44M
Vol293,881.00

About IAM

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.
35

Bearish Sentiment

How do you feel about IAM?

Advertisement|Remove ads.